Shares of Global Medical REIT Inc. (NYSE:GMRE – Get Free Report) have earned a consensus rating of “Moderate Buy” from the seven analysts that are covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $42.50.
Several equities research analysts have recently issued reports on the company. Zacks Research raised Global Medical REIT from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, September 24th. Citizens Jmp upgraded Global Medical REIT from a “market perform” rating to an “outperform” rating and set a $40.00 target price for the company in a research note on Monday, October 13th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Global Medical REIT in a report on Wednesday, October 8th. Wall Street Zen raised Global Medical REIT from a “sell” rating to a “hold” rating in a research report on Saturday, October 18th. Finally, Citigroup upgraded Global Medical REIT to an “outperform” rating in a report on Monday, October 13th.
View Our Latest Research Report on GMRE
Institutional Inflows and Outflows
Global Medical REIT Trading Up 0.0%
NYSE:GMRE opened at $31.08 on Tuesday. The company’s 50 day moving average is $34.61 and its 200-day moving average is $34.47. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.56. Global Medical REIT has a 12 month low of $30.09 and a 12 month high of $47.00. The firm has a market cap of $415.73 million, a price-to-earnings ratio of 88.80 and a beta of 1.19.
Global Medical REIT (NYSE:GMRE – Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.15. The business had revenue of $37.88 million during the quarter, compared to the consensus estimate of $35.57 million. Global Medical REIT had a net margin of 7.32% and a return on equity of 2.21%. Global Medical REIT has set its FY 2025 guidance at 0.890-0.930 EPS. Equities analysts anticipate that Global Medical REIT will post 0.81 EPS for the current year.
Global Medical REIT announced that its Board of Directors has authorized a share repurchase plan on Wednesday, August 13th that authorizes the company to repurchase $50.00 million in shares. This repurchase authorization authorizes the company to purchase up to 11.1% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.
Global Medical REIT Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Monday, September 29th were paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 9.7%. The ex-dividend date was Monday, September 29th. This is an increase from Global Medical REIT’s previous quarterly dividend of $0.15. Global Medical REIT’s dividend payout ratio is currently 857.14%.
About Global Medical REIT
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Recommended Stories
- Five stocks we like better than Global Medical REIT
- How to Find Undervalued Stocks
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- How to Calculate Options Profits
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.
